H. W. Verspaget
- Co-authors
- C. B. H. W. LamersG GriffioenR. A. van HogezandMartin J. WagtmansG. DooijewaardW. van DuijnF J G M KubbenArno M. Janssen
- Topics
- Inflammatory Bowel Disease (6 papers)Microscopic Colitis (6 papers)Protease and Inhibitor Mechanisms (5 papers)
- Partner nations
- NetherlandsItalyUnited States
In The Last Decade
H. W. Verspaget
24 papers receiving 562 citations
Peers
Comparison fields: 5 of 81
- Molecular Biology 173
- Oncology 154
- Cancer Research 153
- Genetics 131
- Surgery 130
Countries citing papers authored by H. W. Verspaget
This map shows the geographic impact of H. W. Verspaget's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. W. Verspaget with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. W. Verspaget more than expected).
Fields of papers citing papers by H. W. Verspaget
This network shows the impact of papers produced by H. W. Verspaget. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. W. Verspaget. The network helps show where H. W. Verspaget may publish in the future.
Co-authorship network of co-authors of H. W. Verspaget
This figure shows the co-authorship network connecting the top 25 collaborators of H. W. Verspaget. A scholar is included among the top collaborators of H. W. Verspaget based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. W. Verspaget. H. W. Verspaget is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 6 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | Basic fibroblast growth factor (BFGF) as a response parameter to infliximab (Remicade)in fistulizing Crohn's disease | 1 |
| 6 | 16 | |
| 7 | 3 | |
| 8 | 1 | |
| 9 | 92 | |
| 10 | 8 | |
| 11 | New therapies for inflammatory bowel disease: an update on chimeric anti-TNF alpha antibodies and IL-10 therapy. | 14 |
| 12 | 40 | |
| 13 | Tumorigenic behaviour of c-Ha-ras oncogene transfected CaCo 2 cells is associated with increased proteolytic potency. | 1 |
| 14 | 48 | |
| 15 | 19 | |
| 16 | 8 | |
| 17 | Natural killer cell activity in patients with adenocarcinoma in the upper gastrointestinal tract. | 21 |
| 18 | Colorectal adenomas: clinical and morphological aspects. A review of 166 polyps from 124 Dutch patients. | 3 |
| 19 | 2 | |
| 20 | 2 |
About H. W. Verspaget
H. W. Verspaget is a scholar working on Transplantation, Applied Microbiology and Biotechnology and Cancer Research, having authored 24 papers that have together received 586 indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (6 papers), Microscopic Colitis (6 papers) and Protease and Inhibitor Mechanisms (5 papers). The work is most often cited by research in Cancer Research (153 citations), Immunology and Allergy (47 citations) and Gastroenterology (38 citations). H. W. Verspaget has collaborated with scholars based in Netherlands, Italy and United States. Frequent co-authors include C. B. H. W. Lamers, G Griffioen, R. A. van Hogezand, Martin J. Wagtmans, G. Dooijewaard, W. van Duijn, F J G M Kubben, Arno M. Janssen, Jan H. Verheijen and J. W. Arndt. Their work appears in journals such as Gut, Journal of Hepatology and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.